Metropolis Healthcare Limited — Quarter ended 31 March 2026 (audited) and year ended 31 March 2026 (audited)
The following tables are extracted from the provided quarterly results document (figures in Rs. in Lakhs unless otherwise stated).
| Sr. No. | Particulars | Quarter ended 31 March 2026 (Audited) (refer note 2) | Quarter ended 31 December 2025 (Unaudited) | Quarter ended 31 March 2025 (Audited) (refer note 2) | Year Ended 31 March 2026 (Audited) | Year Ended 31 March 2025 (Audited) |
|---|---|---|---|---|---|---|
| 1 | Continuing operation | |||||
| Income | ||||||
| a) Revenue from operations | 35,203.12 | 33,471.38 | 31,168.61 | 1,36,547.17 | 1,21,575.19 | |
| b) Other income | 881.67 | 221.58 | 759.57 | 1,633.12 | 1,704.65 | |
| Total Income | 36,084.79 | 33,692.96 | 31,928.18 | 1,38,180.29 | 1,23,279.84 | |
| 2 | Expenses | |||||
| a) Cost of materials consumed | 6,081.79 | 6,232.79 | 6,413.40 | 25,271.78 | 24,448.91 | |
| b) Laboratory testing charges | 568.97 | 424.65 | 266.78 | 1,801.80 | 1,012.38 | |
| c) Employee benefits expense | 7,492.76 | 7,484.91 | 6,864.82 | 29,743.84 | 27,179.87 | |
| d) Finance costs | 656.12 | 436.59 | 442.60 | 1,918.69 | 1,826.00 | |
| e) Depreciation and amortisation expense | 3,279.69 | 2,772.27 | 2,727.47 | 11,616.74 | 10,488.58 | |
| f) Other expenses | 12,044.25 | 11,314.26 | 12,371.61 | 45,907.51 | 42,182.32 | |
| Total Expenses | 30,123.58 | 28,665.47 | 29,086.68 | 1,16,260.36 | 1,07,138.06 | |
| 3 | Profit before exceptional items and tax (1) – (2) | 5,961.21 | 5,027.49 | 2,841.50 | 21,919.93 | 16,141.78 |
| 4 | Exceptional Items (Refer note 8) | – | 795.67 | – | 795.67 | – |
| 5 | Profit before tax (3) – (4) | 5,961.21 | 4,231.82 | 2,841.50 | 21,124.26 | 16,141.78 |
| 6 | Tax expenses | |||||
| Current tax : | ||||||
| – for the year: | 1,889.62 | 776.06 | 617.61 | 5,718.61 | 4,014.36 | |
| – tax adjusted for earlier years: | – | – | – | 37.00 | (63.18) | |
| Deferred tax (credit)/charge | (254.48) | 252.63 | (144.70) | (345.45) | (243.71) | |
| Total tax expenses (Net) | 1,635.14 | 1,028.69 | 472.91 | 5,410.16 | 3,707.47 | |
| 7 | Profit for the year from continuing operations (5) – (6) | 4,326.07 | 3,203.13 | 2,368.59 | 15,714.10 | 12,434.31 |
| 8 | Discontinued Operations | |||||
| (Loss)/Profit from discontinued operation | (3.28) | 0.19 | 22.01 | 45.75 | 60.52 | |
| Tax expense of discontinued operations | (0.83) | 0.05 | 5.54 | 11.52 | 15.23 | |
| Profit from discontinued operations (after tax) | (2.45) | 0.14 | 16.47 | 34.23 | 45.29 | |
| 9 | Profit for the period/year (7) + (8) | 4,323.62 | 3,203.27 | 2,385.06 | 15,748.33 | 12,479.60 |
| 10 | Other comprehensive income | |||||
| Items that will not be reclassified subsequently to profit and loss (net of tax) | 44.06 | 217.89 | 89.52 | (17.53) | (167.89) | |
| Items that will be subsequently reclassified to profit and loss (net of tax) | – | – | – | – | – | |
| Other comprehensive income for the period /year (net of tax) | 44.06 | 217.89 | 89.52 | (17.53) | (167.89) | |
| 11 | Total comprehensive income (9) + (10) | 4,367.68 | 3,421.16 | 2,474.58 | 15,730.80 | 12,311.71 |
| 12 | Paid-up equity share capital (face value – Rs. 2 per share) | 4,146.57 | 1,036.45 | 1,036.01 | 4,146.57 | 1,036.01 |
| 13 | Other equity | – | – | – | 1,34,763.96 | 1,23,408.56 |
| 14 | Earning per share from continuing operation | |||||
| Earnings per share (Face value of Rs. 2 each) basic – (Rs.)* | 2.09 | 1.55 | 1.16 | 7.60 | 6.01 | |
| Earnings per share (Face value of Rs. 2 each) diluted – (Rs.)* | 2.09 | 1.54 | 1.15 | 7.60 | 6.01 | |
| 15 | Earning per share from discontinuing operation | |||||
| Earnings per share (Face value of Rs. 2 each) basic – (Rs.)* | (0.00) | 0.00 | 0.01 | 0.02 | 0.02 | |
| Earnings per share (Face value of Rs. 2 each) diluted – (Rs.)* | (0.00) | 0.00 | 0.01 | 0.02 | 0.02 |
| Particulars | As at 31 March 2026 (Audited) | As at 31 March 2025 (Audited) |
|---|---|---|
| I. ASSETS | ||
| Non-current assets | ||
| Property, plant and equipment | 17,480.30 | 16,868.65 |
| Right-of-use assets | 16,436.37 | 16,014.07 |
| Goodwill | 41,542.55 | 41,542.55 |
| Other intangible assets | 38,062.91 | 38,485.48 |
| Financial assets | ||
| i) Investments | 34,895.74 | 25,554.66 |
| ii) Loans | 136.26 | 79.76 |
| iii) Other financial assets | 1,794.77 | 2,312.22 |
| Non-current tax assets (net) | 1,551.56 | 1,901.77 |
| Other non-current assets | 526.37 | 118.79 |
| Total Non-current assets | 1,52,426.83 | 1,42,877.95 |
| Current assets | ||
| Inventories | 3,221.02 | 3,155.46 |
| Financial assets | ||
| i) Investments | 13,477.60 | 6,559.90 |
| ii) Trade receivables | 11,887.05 | 11,366.50 |
| iii) Cash and cash equivalents | 2,006.35 | 2,268.39 |
| iv) Bank balance other than cash and cash equivalents | 48.50 | 283.92 |
| v) Loans | 79.80 | 78.08 |
| vi) Other financial assets | 1,136.82 | 517.58 |
| Other current assets | 2,762.16 | 1,382.30 |
| Assets held for sale | 1.89 | – |
| Total Current assets | 34,621.19 | 25,612.13 |
| TOTAL ASSETS | 1,87,048.02 | 1,68,490.08 |
| II. EQUITY AND LIABILITIES | ||
| Equity | ||
| Equity share capital | 4,146.57 | 1,036.01 |
| Other equity | 1,34,763.96 | 1,23,408.56 |
| Total Equity | 1,38,910.53 | 1,24,444.57 |
| Non-current liabilities | ||
| Financial liabilities | ||
| i) Lease liabilities | 11,826.30 | 10,165.76 |
| ii) Other financial liabilities | 137.70 | – |
| Provisions | 2,918.89 | 2,307.33 |
| Deferred tax liabilities (net) | 6,713.18 | 7,064.52 |
| Total Non-current liabilities | 21,596.07 | 19,537.61 |
| Current liabilities | ||
| Financial liabilities | ||
| i) Lease liabilities | 6,367.14 | 7,672.34 |
| ii) Trade payables | ||
| – Total outstanding due to micro enterprises and small enterprises | 343.59 | 296.89 |
| – Total outstanding dues of creditors other than micro enterprises and small enterprises | 11,183.11 | 10,408.79 |
| iii) Other financial liabilities | 1,549.65 | 2,062.77 |
| Other current liabilities | 1,710.46 | 1,432.05 |
| Provisions | 1,326.73 | 717.72 |
| Current tax liabilities (net) | 4,060.74 | 1,917.34 |
| Total Current liabilities | 26,541.42 | 24,507.90 |
| TOTAL Liabilities | 48,137.49 | 44,045.51 |
| TOTAL EQUITY AND LIABILITIES | 1,87,048.02 | 1,68,490.08 |
| Particulars | As at 31 March 2026 (Audited) | As at 31 March 2025 (Audited) |
|---|---|---|
| A Cash flows from operating activities | ||
| Profit before tax | 21,170.01 | 16,202.30 |
| Adjustments for : | ||
| Exceptional item | 795.67 | |
| Depreciation and amortisation expense | 11,617.04 | 10,488.93 |
| Interest paid on lease liabilities | 1,912.26 | 1,824.23 |
| Changes in fair value of current investments | 90.03 | (223.43) |
| Loss/(Profit) on sale of Property, Plant and Equipment (net) | 38.29 | (175.93) |
| Provision for bad and doubtful debts (net) | 60.05 | 517.37 |
| Reversal for bad and doubtful advances (net) | (58.50) | |
| Share based payments (net) | 733.43 | 700.78 |
| Interest on deferred purchase consideration | 6.43 | 1.77 |
| Unrealised foreign exchange (gain)/loss (net) | (89.64) | 251.60 |
| Sundry balances written back | (14.59) | (196.39) |
| Gain on writeback of deferred purchase consideration | (500.00) | |
| Gain on redemption of current investment | (398.03) | (512.78) |
| Credit impaired trade receivables written off | 2,243.53 | 279.87 |
| Interest income | (167.76) | (188.72) |
| Interest income on income tax refund | (86.40) | (70.89) |
| Gain on Termination of Leases | (46.58) | |
| Operating profit before working capital changes | 37,363.74 | 28,840.21 |
| Working capital adjustments: | ||
| (Increase)/Decrease in inventories | (65.56) | 233.65 |
| (Increase)/Decrease in other assets (current and non-current) | (1,369.63) | 242.69 |
| (Increase)/Decrease in trade receivables | (2,715.10) | 626.66 |
| (Increase) in other financial assets | (180.96) | (131.91) |
| Increase in provisions | 401.45 | 208.81 |
| Increase in trade payables | 820.32 | 1,366.75 |
| Increase/(Decrease) in other financial liabilities | 428.38 | (113.35) |
| Increase/(Decrease) in other current liabilities | 293.00 | (611.32) |
| Cash flows generated from operating activities | 34,975.64 | 30,662.18 |
| Income taxes (paid) | (3,187.11) | (3,378.91) |
| Net cash flows generated from operating activities (A) | 31,788.53 | 27,283.27 |
| B Cash flows from investing activities | ||
| Purchase of property, plant and equipment | (2,977.94) | (3,853.26) |
| Purchase of other intangible assets & intangible assets under development | (729.27) | (2,514.27) |
| Proceeds from sale of property, plant and equipment | 200.00 | |
| Deferred purchase consideration | (41.76) | |
| Purchase of current investments | (47,855.92) | (52,122.67) |
| Purchase consideration paid towards acquisition of business | (1,530.00) | |
| Proceeds from sale of current investments | 41,246.22 | 51,606.47 |
| Investments in subsidiaries through equity instruments | (3.02) | (13,077.18) |
| Loan given to subsidiary | (73.60) | 217.44 |
| Loan repaid by subsidiary | 5.00 | |
| Interest received on loan given to subsidiary | 10.84 | |
| Interest received | 19.77 | 76.65 |
| Investments in subsidiaries |